WeVote

Bill

Bill

SB 322

Removing the authority of the state board of pharmacy to authorize individuals to access the prescription monitoring program database by rules and regulations.

2025-2026 Regular Session

Kansas bill strips pharmacy board's rulemaking power to authorize prescription database access, requiring legislature to approve all new users instead.

Died in House Committee
0
WeVote Research Nonpartisan
Bill Summary · SB 322

Legislative bill overview

SB 322 removes the State Board of Pharmacy's authority to create rules allowing individuals to access Kansas's prescription monitoring program (PMP) database. Instead of allowing the board regulatory flexibility, the bill would require any access authorization to come directly from the legislature through statutory law rather than administrative regulation.

Why is this important

Prescription monitoring programs track controlled substance prescriptions to prevent drug abuse and diversion. This change shifts decision-making power from pharmacy regulators (who have technical expertise in drug control) to the legislature, potentially slowing how quickly healthcare providers, law enforcement, or other authorized entities can gain database access when public health needs emerge.

Potential points of contention

  • Regulatory flexibility vs. legislative oversight: Removes the board's ability to adapt PMP access rules quickly in response to evolving drug threats; any new authorized users would require full legislative action
  • Access delays: Healthcare providers, addiction specialists, or other professionals may face extended periods unable to access critical drug-history data if legislative action is slow or delayed
  • Who loses access: Unclear which current database users authorized under existing board rules would retain access under statute-only requirements, potentially disrupting ongoing medical or law enforcement operations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.